Breaking News Instant updates and real-time market news.

BA

Boeing

$133.94

0.5566 (0.42%)

, AMGN

Amgen

$164.29

0.41 (0.25%)

13:02
10/14/16
10/14
13:02
10/14/16
13:02

Boeing names Amgen CEO Robert Bradway to board

The Boeing (BA) board of directors has elected Robert A. Bradway as a new member. Bradway is chairman and CEO of Amgen (AMGN).

BA

Boeing

$133.94

0.5566 (0.42%)

AMGN

Amgen

$164.29

0.41 (0.25%)

  • 26

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Jul

BA Boeing
$133.94

0.5566 (0.42%)

06/23/16
06/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), eBay (EBAY), and Groupon (GRPN) initiated with a Buy at Maxim. 2. Boeing (BA) initiated with an Overweight at Morgan Stanley. 3. Wal-Mart (WMT) coverage assumed with a Buy at Nomura. 4. Textron (TXT) initiated with an Underweight at Morgan Stanley. 5. ANI Pharmaceuticals (ANIP) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/16
BERN
07/28/16
NO CHANGE
BERN
Boeing reported beat and raise results, says Bernstein
Bernstein analyst Douglas Harned says that Boeing reported higher than expected Q1 EPS and effectively raised its EPS guidance by $1..18 per share. Harned says that the company's 787 unit margins appear to be running ahead of expectations. He expects the company to generate strong cash flow growth going forward. Harned keeps a $176 price target and Outperform rating on the stock.
10/05/16
BARD
10/05/16
INITIATION
BARD
Outperform
Boeing initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Boeing with an Outperform and a $161 price target.
10/06/16
10/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with an Outperform at Baird. 2. AMC Networks (AMCX) initiated with an Outperform at FBN Securities. 3. CVS Health (CVS) initiated with a Buy at UBS. 4. L-3 Communications (LLL) initiated with an Outperform at Baird. 5. Raytheon (RTN) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AMGN Amgen
$164.29

0.41 (0.25%)

09/01/16
09/01/16
NO CHANGE

Amgen's sBLA for Blincyto approved by FDA
Amgen's supplemental Biologics License Application for Blincyto has been approved by the FDA to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. This indication is approved under accelerated approval, and continued approval may be contingent upon verification of clinical benefit in subsequent trials. The approval is based on results from the Phase 1/2 '205, an open-label, multicenter, single-arm trial, which evaluated the efficacy and safety of BLINCYTO in pediatric patients with relapsed or refractory B-cell precursor ALL. Blincyto was granted breakthrough therapy, priority review and orphan drug designations by FDA, and is now approved in the U.S. for the treatment of Ph- relapsed or refractory B-cell precursor ALL. In November 2015, BLINCYTO was granted conditional marketing authorization in the European Union for the treatment of adults with Ph- relapsed or refractory B-cell precursor ALL.
09/27/16
GSCO
09/27/16
NO CHANGE
Target $206
GSCO
Conviction Buy
Goldman surprised by Amgen's Kyprolis outcome in first-line multiple myeloma
Last night, Amgen announced Phase 3 Kypolis CLARION study did not meet the primary endpoint in first-line multiple myeloma. Goldman analyst Terence Flynn was surprised by this outcome given the prior positive superiority data for Kyprolis versus Velcade in the Phase III ENDEAVOR trial. Flynn sees risk to his Kyprolis $1B sales estimate in a first-line setting, but awaits for additional details from the call and further information regarding another ongoing Phase III trial. He expects Amgen shares to be weak on the news but said the company has additional drivers beyond Kyprolis including Repatha for high cholesterol and Erenumab for migraine with additional data expected in 2H 2016 and Q1 2017. Flynn remains Conviction Buy rated on Amgen and maintains his $206 price target.
09/27/16
PIPR
09/27/16
NO CHANGE
PIPR
Overweight
Amgen's Kyprolis in good shape despite trial miss, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Amgen's Kyprolis is still likely to be viewed as a "potent backbone, with the right drugs" after a Phase 3 study in front-line myeloma failed to reach its primary endpoint. The analyst believes the impact of the failed trial on Kyprolis use will be limited and he reiterates an Overweight rating on Amgen.
09/29/16
PIPR
09/29/16
NO CHANGE
Target $10
PIPR
Overweight
Arrowhead price target raised to $10 from $8 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Arrowhead Pharmaceuticals (ARWR) to $10 after the company licensed two preclinical cardiovascular RNAi drugs with Amgen (AMGN). Amgen is the "ideal partner" and Arrowhead's balance sheet is now "meaningfully" strengthened, Tenthoff tells investors in a research note. He reiterates an Overweight rating on Arrowhead.

TODAY'S FREE FLY STORIES

VBIV

VBI Vaccines

$4.36

-0.1 (-2.24%)

08:10
01/17/18
01/17
08:10
01/17/18
08:10
Hot Stocks
VBI Vaccines doses first patient in Phase 1/2a clinical study of VBI-1901 »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DERM

Dermira

$26.96

-0.48 (-1.75%)

08:09
01/17/18
01/17
08:09
01/17/18
08:09
Recommendations
Dermira analyst commentary  »

Dermira price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

LFUS

Littelfuse

$205.55

-0.9 (-0.44%)

, IXYS

IXYS

$23.05

-1.55 (-6.30%)

08:09
01/17/18
01/17
08:09
01/17/18
08:09
Hot Stocks
Littelfuse completes acquisition of IXYS »

Littelfuse (LFUS)…

LFUS

Littelfuse

$205.55

-0.9 (-0.44%)

IXYS

IXYS

$23.05

-1.55 (-6.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

DKS

Dick's Sporting

$32.33

-1 (-3.00%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Technical Analysis
Technical Take: Dick's Sporting higher in pre-market, analyst action »

At time of writing, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Conference/Events
Board of Governors of the Federal Reserve System holds a closed meeting »

The Board of Governors of…

MGP

MGM Growth

$29.50

0.96 (3.36%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Hot Stocks
VICI Properties rejects unsolicited proposal from MGM Growth »

VICI Properties confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$2.31

-0.07 (-2.94%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Hot Stocks
Pareteum awarded $3M contract to add mobility to South American data provider »

Pareteum has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSOD

Cornerstone OnDemand

$38.94

-0.23 (-0.59%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
Cornerstone OnDemand to separate chairman and CEO roles »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 13

    Mar

ATVI

Activision Blizzard

$68.71

-1.65 (-2.35%)

, AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
Overwatch League opening week draws more than 10M viewers »

The Overwatch League…

ATVI

Activision Blizzard

$68.71

-1.65 (-2.35%)

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

NTES

NetEase

$322.08

-6.75 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 07

    Feb

  • 08

    Feb

  • 18

    Mar

KNX

Knight-Swift

$44.63

-0.37 (-0.82%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Conference/Events
Knight-Swift management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 30

    Jan

MPLX

MPLX

$38.28

-0.5 (-1.29%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
MPLX announces joint open season for Cushing-to-Patoka pipeline expansion »

MPLX announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$232.90

4.26 (1.86%)

08:06
01/17/18
01/17
08:06
01/17/18
08:06
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$167.54

-1.76 (-1.04%)

08:06
01/17/18
01/17
08:06
01/17/18
08:06
Recommendations
Deere analyst commentary  »

Deere price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

RIOT

Riot Blockchain

$18.28

-3.6 (-16.45%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Hot Stocks
Riot Blockchain's Tess Pay signs agreement for Cresval Capital transaction »

Riot Blockchain's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

WAFD

Washington Federal

$35.60

-0.05 (-0.14%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Earnings
Washington Federal reports Q4 EPS 59c, consensus 51c »

Return on equity for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Earnings
Ichor Holdings sees Q1 revenue $240M-$250M, consensus $208.35M »

For 1Q18, Ichor expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OBE

Obsidian Energy

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Hot Stocks
FrontFour Capital voices concerns regarding Obsidian Energy »

FrontFour Capital Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$54.90

0.07 (0.13%)

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Downgrade
HSBC rating change  »

HSBC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Earnings
Ichor Holdings sees Q4 revenue $183M, consensus $181.17M »

Ichor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

RGC

Regal Entertainment

$22.90

-0.07 (-0.30%)

08:03
01/17/18
01/17
08:03
01/17/18
08:03
Downgrade
Regal Entertainment rating change  »

Regal Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.55 (-2.93%)

08:03
01/17/18
01/17
08:03
01/17/18
08:03
Hot Stocks
GE Transportation signs locomotive, service agreements valued at over $900M »

GE Transportation signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

DWDP

DowDuPont

$74.95

-0.46 (-0.61%)

08:02
01/17/18
01/17
08:02
01/17/18
08:02
Hot Stocks
DowDuPont, UC Davis team up to advance orphan African crops »

Dow AgroSciences teamed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

08:02
01/17/18
01/17
08:02
01/17/18
08:02
Downgrade
Adient rating change  »

Adient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

NTN

NTN Buzztime

$4.91

0.3 (6.51%)

, BWLD

Buffalo Wild Wings

$156.65

-0.1 (-0.06%)

08:02
01/17/18
01/17
08:02
01/17/18
08:02
Hot Stocks
NTN Buzztime digital menu and payment go live at Buffalo Wild Wings »

NTN Buzztime (NTN), has…

NTN

NTN Buzztime

$4.91

0.3 (6.51%)

BWLD

Buffalo Wild Wings

$156.65

-0.1 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMMA

Alliance MMA

$0.87

0.04 (4.82%)

08:02
01/17/18
01/17
08:02
01/17/18
08:02
Hot Stocks
Alliance MMA, FloSports announce event rights fee deal »

Alliance MMA announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.